医学
放射外科
内科学
肺癌
化疗
肿瘤科
放射治疗
作者
Ammoren Dohm,Joseph D. Tang,Matthew N. Mills,Casey Liveringhouse,María L. Sandoval,Bradford A. Perez,Timothy J. Robinson,Ben Creelan,Jhanelle E. Gray,Arnold B. Etame,Michael A. Vogelbaum,Peter Forsyth,Ya-Yu Tsai,Daniel Oliver,Kamran A. Ahmed
出处
期刊:Journal of Neurosurgery
[American Association of Neurological Surgeons]
日期:2022-11-18
卷期号:138 (6): 1600-1607
被引量:15
标识
DOI:10.3171/2022.9.jns221896
摘要
Immune checkpoint inhibitors (ICIs) and epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are commonly used in the systemic management of non-small cell lung cancer (NSCLC) brain metastases (BMs). However, optimizing control of NSCLC BM with stereotactic radiosurgery (SRS) and various systemic therapies remains an area of investigation.
科研通智能强力驱动
Strongly Powered by AbleSci AI